FDA To Review Teva and Alvotech Drug That Could Compete With Regeneron's Eylea
Teva Pharmaceutical Industries and partner Alvotech said the Food and Drug Administration agreed to review their AVTO6 ...
FiercePharma12h
As BMS-paired triplet misses survival mark in kidney cancer, Exelixis shifts focus elsewhere
Newly published detailed clinical trial data show why Exelixis abandoned a plan to seek an FDA approval for a combination of ...